Medmix Ltd
SIX:MEDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medmix Ltd
Income from Continuing Operations
Medmix Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Income from Continuing Operations
CHf7.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Income from Continuing Operations
-CHf16.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Income from Continuing Operations
CHf527.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Medacta Group SA
SIX:MOVE
|
Income from Continuing Operations
€95.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Income from Continuing Operations
CHf358m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
What is Medmix Ltd's Income from Continuing Operations?
Income from Continuing Operations
7.1m
CHF
Based on the financial report for Dec 31, 2025, Medmix Ltd's Income from Continuing Operations amounts to 7.1m CHF.
What is Medmix Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-6%
The average annual Income from Continuing Operations growth rates for Medmix Ltd have been -15% over the past three years , -6% over the past five years .
